D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
NAGE holding history
Niagen Bioscience, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAGE overviewAll 13F holders of NAGEFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −26,942−100.0% | Sold out | Holders |
| Q3 2025 | 26,942 | $251.4K | <0.1% | −10,032−27.1% | Reduced | Holders |
| Q2 2025 | 36,974 | $532.8K | <0.1% | +25,224+214.7% | Added | Holders |
| Q1 2025 | 11,750 | $81.1K | <0.1% | +11,750 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −21,000−100.0% | Sold out | Holders |
| Q4 2021 | 21,000 | $79.0K | <0.1% | −2,000−8.7% | Reduced | Holders |
| Q3 2021 | 23,000 | $144.0K | <0.1% | −1,000−4.2% | Reduced | Holders |
| Q2 2021 | 24,000 | $237.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 24,000 | $224.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.